Valsts: Lielbritānija
Valoda: angļu
Klimata pārmaiņas: MHRA (Medicines & Healthcare Products Regulatory Agency)
Pericyazine
DE Pharmaceuticals
N05AC01
Pericyazine
10mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 04020100
PACKAGE LEAFLET: INFORMATION FOR THE USER PERICYAZINE 10MG TABLETS READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU ARE GIVEN THIS MEDICINE Keep this leaflet. You may need to read it again If you have any further questions, ask your doctor or pharmacist This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist IN THIS LEAFLET: 1. What pericyazine is and what it is used for 2. Before you take pericyazine 3. How to take pericyazine 4. Possible side effects 5. How to store pericyazine 6. Further Information 1. WHAT PERICYAZINE IS AND WHAT IT IS USED FOR 1. The name of your medicine is Pericyazine 10mg Tablets (referred to as pericyazine throughout this leaflet).This belongs to a group of medicines called ‘phenothiazines’. It works by blocking the effect of a chemical in the brain. It can be used for: Schizophrenia The short term treatment of anxiety, agitation and violent or dangerously impulsive behaviour when used with other medicines 2. BEFORE YOU TAKE PERICYAZINE DO NOT TAKE THIS MEDICINE AND TELL YOUR DOCTOR IF: You are allergic (hypersensitive) to pericyazine or any of the other ingredients in this medicine (listed in Section 6) Signs of an allergic reaction include: a rash, swallowing or breathing problems, swelling of your lips, face, throat or tongue You are pregnant, might become pregnant or think you may be pregnant (see Section below: ‘Pregnancy and breast-feeding’) Do not take this medicine if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before taking pericyazine. TAKE SPECIAL CARE WITH PERICYAZINE CHECK WITH YOUR DOCTOR OR PHARMACIST BEFORE YOU TAKE THIS MEDICINE IF: You have heart problems or a family history of heart problems You have ever had a stroke You have liver or kidney problems You hav Izlasiet visu dokumentu
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Pericyazine 10mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Pericyazine 10mg Excipients with known effect: Methyl hydroxybenzoate: Each 10mg tablet contains 0.003 mg benzoate salt. Lactose: Each 10mg tablet contains 112.5mg lactose. For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Pericyazine 10mg Tablets: Circular, very pale lime-yellow tablet, with one face impressed ‘S172’ and a break-line on reverse. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS a) In adults with schizophrenia or other psychoses, for the treatment of symptoms or prevention of relapse. b) In anxiety, psychomotor agitation, violent or dangerously impulsive behaviour. Pericyazine is used as an adjunct to the short-term management of these conditions. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _Route of administration_: oral . Dosage requirement varies with the individual and the severity of the condition being treated. Initial dosage should be low with progressive increases until the desired response is obtained, after which dosage should be adjusted to maintain control of the symptoms. _ Severe conditions _ _Indication (a) _ _ _ Adults:_ _Initially 75 mg per day in divided doses. Dosage should be increased by 25 mg per day at weekly intervals until the optimum effect is achieved. Maintenance therapy would not normally be expected to exceed 300 mg per day. Elderly: _ _Initially 15-30 mg per day in divided doses. If this is well tolerated the dosage may be increased if necessary for optimum control of behaviour. _Mild or moderate conditions _ _ _ _Indication (b) _ _ _ Adults: Initially 15-30 mg daily, divided into two portions with a larger dose being given in the evening. Elderly: 5-10 mg per day is suggested as a starting dose. It may be divided so that a larger portion is given in the evening. Half or quarter the normal adult dose may be sufficient for maintenance therapy. Pericyazine tablets are not recommended for children. 4.3 CONTRAINDI Izlasiet visu dokumentu